AIF1 and Alzheimer disease: For example, most studies we identified that investigated the relationship of IBA1 and AD had relied on pooling samples into broad patient categories, such as those with a clinical diagnosis of any type of AD and those that are neurocognitively normal, and thus did not overtly consider any subtypes of AD or patient demographics [14, 34–42].